Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT
Stevens Christopher James received 73,313 Rocket Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, Stevens Christopher James (Chief Operating Officer) received 73,313 Rocket Pharmaceuticals, Inc. shares as an award, leaving 542,442 shares. Filed Aug 5, 2026 (Form 4).
- Awarded
- 73,313 shares
- Holding after
- 542,442 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Award | 73,313 | 542,442 | Direct |
Source
Related
- Rocket Pharmaceuticals, Inc.
- Stevens Christopher James
- Rocket Pharmaceuticals, Inc. shareholders
- Form 4 · Stevens Christopher James · Aug 13, 2026
- Form 4 · Wilson Martin · Sep 15, 2026
- Form 4 · Wilson Martin · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 17, 2026
- Form 4 · Wilson Martin · Aug 17, 2026